Photo

Photo detail

David Karow is Human Longevity’s recently named interim CEO. New leadership wants to open testing centers in new areas. Photos courtesy of Human Longevity

Stories this photo appears in:

After Turmoil, Human Longevity Sharpens Focus on Commercialization

GENOMICS: Exec Says Co. Has Cash, Runway to Next Phase

New leadership at Human Longevity is seeking to emerge from a tumultuous period of executive exodus and workforce reduction through a bid to bring its genomics-based testing center to a wider market.

Tease photo